Drew Weissman (Drew Weissman)
Developers of synthetic messenger RNA technology
Weisman was born in Lesington (Lexington, Massachusetts)
B.A. and Master's Degree from Brandeis University in Biochemistry and Enzymology
1987 graduated in Microbiology and Immunology from Boston University.
After graduating, he worked at Beth Israel Hospital in Boston.
1990, took office at the U.S. National Institutes of Health, NIH.
He worked in 1993 at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institute of Public Health. Weisman was on Dr. Nassar's senior assistant team. Anthony Fauci, who is also the director of the NIAID, is also the director of the NIAID.
In 1997, he worked at the University of Pennsylvania as an immunologist who led Weisman to meet Catalin Kariko, who was already working on research here.
When it comes to m.m. Pennsylvania Weisman was interested in developing a vaccine against HIV by developing a DNA vaccine, but it was not successful. But when she met Carico, she gave Weisman a research on her mRNA.
2005 Jan. Pennsylvania, together with Weisman and Catalin, patented on the modification of RNA so that it can be injected into the human body without the destruction of immunity. Soon, this patent was sold to BionTech, Pfizer and Moderna.
In 2006, co-founded RNaX with Catalin. The company aims to use RNA for therapeutic purposes.
2020 receives Rosenstiel Award in conjunction with Catalan Carico
Dr. Weisman participated in ChulaCov Vaccine Development Project, Covid-19 Vaccine with Chulalongkorn University
Currently, he also develops five other vaccines, with mRNA technology such as sickel cell anemia, herpes, HIV, flu. Funded by the Bill and Melinda Gates Foundation.